Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement

Health and Quality of Life Outcomes

Volumn 13, Issue 1, 2015, Pages

  Petrou, Stavros ^a   Rivero Arias, Oliver ^b   Dakin, Helen ^b   Longworth, Louise ^c   Oppe, Mark ^d   Froud, Robert ^a,e   Gray, Alastair ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d EuroQol Research Foundation   (Netherlands)

^e EuroQol Research Foundation ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; INFORMATION DISSEMINATION; MAPPING ONTO PREFERENCE BASED MEASURE REPORTING STANDARD; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; PUBLICATION; QUALITY OF LIFE; BIBLIOMETRICS; CHECKLIST; MEDICAL RESEARCH; PEER REVIEW; STANDARDS;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; CHECKLIST; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC;

EID: 84938086650     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-015-0305-6     Document Type: Article

References (27)

1. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215-25. doi: 10.1007/s10198-009-0168-z. 1425919854.
2. Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes. 2013;11:151. doi: 10.1186/1477-7525-11-151. 1425925341.
3. Chuang LH, Whitehead SJ. Mapping for economic evaluation. Br Med Bull. 2012;101:1-15. doi: 10.1093/bmb/ldr049. 1427393724.
4. Longworth L, Rowen D. NICE DSU Technical Support Document 10: The Use of Mapping Methods to Estimate Health State Utility Values. Sheffield, UK: Decision Support Unit, ScHARR, University of Sheffield; 2011.
5. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2), e1000217. doi: 10.1371/journal.pmed.1000217. 1425988566.
6. Moher D, Simera I, Schulz KF, Hoey J, Altman DG. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med. 2008;6:13. doi: 10.1186/1741-7015-6-13. 1425989043.
7. Narahari SR, Ryan TJ, Aggithaya MG, Bose KS, Prasanna KS. Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model. J Altern Complement Med. 2008;14(6):769-76. doi: 10.1089/acm.2007.0818. 1425997359.
8. Mortimer D, Segal L, Sturm J. Can we derive an 'exchange rate' between descriptive and preference-based outcome measures for stroke? Results from the transfer to utility (TTU) technique. Health Qual Life Outcomes. 2009;7:33. doi: 10.1186/1477-7525-7-33. 1426002631.
9. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138(1):W1-12. 1426070562.
10. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-57. doi: 10.1093/intqhc/mzm042. 1426070607.
11. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10), e297. doi: 10.1371/journal.pmed.0040297. 1426070521.
12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. 1426070400.
13. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869. 1426070468.
14. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231-50. doi: 10.1016/j.jval.2013.02.002. 1426070220.
15. Fitch K, Bernstein S, Aguilar M, Burnand B, LaCalle J, Lazaro P, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica; 2001.
16. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. The MAPS reporting statement for studies mapping onto generic preference-based outcome measures: Explanation and elaboration. PharmacoEconomics, in press. 1428428637. http://dx.doi.org/10.1007/s40273-015-0312-9
17. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271-92. 1426244550.
18. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7(6):490-502. 1426244646.
19. Yang Y, Wong MY, Lam CL, Wong CK. Improving the mapping of condition-specific health-related quality of life onto SF-6D score. Qual Life Res. 2014;23(8):2343-53. doi: 10.1007/s11136-014-0668-x. 1426244912.
20. Lee L, Kaneva P, Latimer E, Feldman LS. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores. J Surg Res. 2014;186(1):135-41. doi: 10.1016/j.jss.2013.08.006. 1426244970.
21. Roset M, Badia X, Forsythe A, Webb SM. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome. Patient. 2013;6(2):103-11. doi: 10.1007/s40271-013-0010-7. 1426245033.
22. Payakachat N, Tilford JM, Kuhlthau KA, van Exel NJ, Kovacs E, Bellando J, et al. Predicting health utilities for children with autism spectrum disorders. Autism Res. 2014;7(6):649-63. doi: 10.1002/aur.1409. 1426245111.
23. Goldfeld KS, Hamel MB, Mitchell SL. Mapping health status measures to a utility measure in a study of nursing home residents with advanced dementia. Med Care. 2012;50(5):446-51. doi: 10.1097/MLR.0b013e3182407e0d. 1426245177.
24. Chen G, McKie J, Khan MA, Richardson JR. Deriving health utilities from the MacNew Heart Disease Quality of Life Questionnaire. Eur J Cardiovasc Nurs. 2014. doi: 10.1177/1474515114536096. 1426245245.
25. Moher D, Jones A, Lepage L, Group C. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285(15):1992-5. 1426256489.
26. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ. A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care. 2005;9(5):R575-82. doi: 10.1186/cc3803. 1426256559.
27. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust. 2006;185(5):263-7. 1426256647.